Work

Utilization and Early Discontinuation of First-Line Ibrutinib for Patients with Chronic Lymphocytic Leukemia Treated in the Community Oncology Setting in the United States

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-122054

Authors: Scott F. Huntington, Pamela R. Soulos, Paul M. Barr, Ryan Jacobs, Frederick Lansigan, Oreofe O. Odejide, Lee S. Schwartzberg, Amy J. Davidoff, Cary P Gross

Institutions: Yale Cancer Center, Yale University, University of Rochester Medicine, University of Rochester, Levine Cancer Institute, Dartmouth–Hitchcock Medical Center, Dana-Farber Cancer Institute, West Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2990313059

Cites:

Cited by: 4

Related to: 10